People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, AI / ML, Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Concentric Analgesics, Inc. | — | Biotechnology | Series C | $130.8M | $478.1M | 2017 |
| Cresta Intelligence Inc. | — | AI / ML | Series D+ | $125.0M | $1.5B | 2024 |
| Alios Biopharma Inc | — | Pharmaceuticals | Series C | $82.3M | $1.4B | 2014 |
| Neural Analytics, Inc. | — | AI / ML | Series B | $81.8M | $258.0M | 2021 |
| LendingClub Corp | — | Other | Series B | $61.5M | $415.4M | 2009 |
| Olea Networks, Inc. | — | Other Technology | Series B | $50.5M | $695.8M | 2018 |
| Tolerion, Inc. | — | Biotechnology | Series B | $43.0M | $793.8M | 2017 |
| Renavance Pharma, Inc. | — | Pharmaceuticals | Pre-Seed | $600K | $4.7M | 2009 |
John Donovan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Donovan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Nielsen | 1 | 13 |
| Rebecca Lynn | 1 | 12 |
| Yuri Pikover | 1 | 9 |
| Douglas Leone | 1 | 9 |
| Campbell Murray | 1 | 9 |
| Jeff Crowe | 1 | 9 |
| Jens Eckstein | 1 | 8 |
| Dan Watkins | 1 | 8 |
| Daniel Ciporin | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Thomas King | 1 | 6 |
| Paul Manning | 1 | 6 |
| David Pearce | 1 | 5 |
| David Settle | 1 | 5 |
| Sean Stalfort | 1 | 5 |
| Lawrence Steinman | 1 | 4 |
| Rob Theis | 1 | 4 |
| TED KOUTOUZIS | 1 | 4 |
| Jimmy Treybig | 1 | 3 |
| Lawrence Blatt | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.